Star Cement (540575) Q4 14/15 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 14/15 earnings summary
26 Oct, 2026Executive summary
FY2014-15 consolidated cement production rose 31% to 2.17 million tonnes; cement sales rose 33% to 2.17 million tonnes, with capacity expansion and broader market reach supporting growth.
Consolidated net sales reached ₹143,042.78 lakh, up 39%; EBITDA rose 85% to ₹43,723.31 lakh, and profit after minority interest was ₹11,865.39 lakh versus a ₹419.88 lakh loss.
Financial highlights
Consolidated revenue from operations, net of excise duty, was ₹143,042.78 lakh versus ₹102,798.95 lakh; total revenue was ₹143,120.91 lakh versus ₹103,060.96 lakh.
Consolidated PBT was ₹12,612.41 lakh versus a ₹479.26 lakh loss; profit after tax before minority interest was ₹12,132.28 lakh.
Standalone net sales were ₹111,408.52 lakh versus ₹73,675.38 lakh; standalone profit after tax was ₹4,602.63 lakh versus a ₹1,569.38 lakh loss.
Consolidated operating cash flow was ₹26,172.07 lakh, compared with ₹23,299.38 lakh in FY2013-14.
Outlook and guidance
Cement demand was expected to grow by more than 8% over the next three years; industry utilisation was forecast to reach 75% in FY2016 and 79% in FY2017, versus 72% in FY2014.
Plans focus on deeper penetration in North East India and expansion into additional Eastern states; management expected improved volumes in West Bengal, Bihar and adjoining Jharkhand.
Ongoing infrastructure, roads, housing, ports and power projects, together with relatively low regional cement consumption, were cited as demand opportunities.
Latest events from Star Cement
- Revenue rose, consolidated profit fell, and the ₹1,500 crore fund raise was deferred.540575
Q2 26/27 - Record FY10 earnings and expansion plans face rising input-cost pressure.540575
Q4 09/10 - Record output and expansion plans countered cost pressure and softer consolidated profits.540575
Q4 10/11 - Volume gains and expansion advanced despite falling profits and surging costs.540575
Q4 11/12 - New capacity and market expansion plans amid sharply lower profit and rising costs.540575
Q4 12/13 - New capacity drove rapid growth, but higher financing and depreciation costs kept FY14 in loss.540575
Q4 13/14 - Volumes and revenue grew, but lower realizations and higher costs cut EBITDA.540575
Q4 15/16 - Record profits and sharp debt reduction set the stage for capacity-led growth.540575
Q4 17/18 - Profit rose despite a weak market, while regional sales and capacity expansion advanced.540575
Q4 16/17